Marie Elisabeth Wahren Herlenius's picture

Marie Elisabeth Wahren Herlenius

Academic article
  • Show author(s) (2023). Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open. 21 pages.
  • Show author(s) (2023). Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor. Frontiers in Immunology.
  • Show author(s) (2023). Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies. EBioMedicine. 12 pages.
  • Show author(s) (2023). Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies. Journal of Autoimmunity. 14 pages.
  • Show author(s) (2023). Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open. 19 pages.
  • Show author(s) (2023). 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice. Annals of the Rheumatic Diseases. 754-762.
  • Show author(s) (2022). Strong association of combined genetic deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis & Rheumatology. 1842-1850.
  • Show author(s) (2022). Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases. Arthritis & Rheumatology. 1440-1450.
  • Show author(s) (2022). Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function. Annals of the Rheumatic Diseases. 1151-1161.
  • Show author(s) (2021). SOCS3 Expression by Thymic Stromal Cells Is Required for Normal T Cell Development. Frontiers in Immunology. 17 pages.
  • Show author(s) (2021). Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block. Annals of the Rheumatic Diseases. 194-202.
  • Show author(s) (2021). Interferons and innate immune activation in autoimmune congenital heart block. Scandinavian Journal of Immunology.
  • Show author(s) (2021). Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. Rheumatology. 1445-1455.
  • Show author(s) (2020). Cigarette smoking patterns preceding primary Sjögren's syndrome. RMD Open. 1-9.
Academic literature review
  • Show author(s) (2023). Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies. Nature Reviews Rheumatology. 288-306.
Article in business/trade/industry journal
  • Show author(s) (2022). Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 979-989.

More information in national current research information system (CRIStin)